Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

IS FECAL CALPROTECTIN AN ACCURATE MARKER IN THE MANAGEMENT OF CROHN'S DISEASE?

Vernia F, Di Ruscio M, Stefanelli G, Viscido A, Frieri G, Latella G.

J Gastroenterol Hepatol. 2019 Dec 3. doi: 10.1111/jgh.14950. [Epub ahead of print] Review.

PMID:
31795013
2.

Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis.

Viscido A, Latella G, Frieri G.

Am J Gastroenterol. 2019 Dec;114(12):1922-1923. doi: 10.14309/ajg.0000000000000427. No abstract available.

PMID:
31658106
3.

Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?

Pompili S, Sferra R, Gaudio E, Viscido A, Frieri G, Vetuschi A, Latella G.

Int J Mol Sci. 2019 Aug 20;20(16). pii: E4061. doi: 10.3390/ijms20164061. Review.

4.

Duodenal lymphocytosis in functional dyspepsia.

Capannolo A, Necozione S, Gabrieli D, Ciccone F, Sollima L, Melchiorri L, Viscido A, Frieri G.

Arab J Gastroenterol. 2019 Jun;20(2):91-94. doi: 10.1016/j.ajg.2019.05.006. Epub 2019 Jun 4.

PMID:
31175076
5.

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

Viscido A, Papi C, Latella G, Frieri G.

Biologics. 2019 Apr 9;13:23-31. doi: 10.2147/BTT.S179006. eCollection 2019.

6.

Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet.

Ciccone A, Gabrieli D, Cardinale R, Di Ruscio M, Vernia F, Stefanelli G, Necozione S, Melideo D, Viscido A, Frieri G, Latella G.

Digestion. 2019;100(4):262-268. doi: 10.1159/000495749. Epub 2018 Dec 14.

PMID:
30554200
7.

IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature.

Ciccone F, Ciccone A, Di Ruscio M, Vernia F, Cipolloni G, Coletti G, Calvisi G, Frieri G, Latella G.

Dig Dis Sci. 2018 Apr;63(4):1072-1086. doi: 10.1007/s10620-018-4950-6. Epub 2018 Feb 8. Review. No abstract available.

PMID:
29417330
8.

Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?

Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G.

Inflamm Bowel Dis. 2017 Dec 19;24(1):78-92. doi: 10.1093/ibd/izx011. Review.

PMID:
29272479
9.

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine.

Frieri G, Galletti B, Di Ruscio M, Tittoni R, Capannolo A, Serva D, Latella G, Sollima L, Leocata P, Necozione S, Frieri R, Viscido A.

Therap Adv Gastroenterol. 2017 Oct;10(10):749-759. doi: 10.1177/1756283X17722926. Epub 2017 Aug 25.

10.

Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet.

Benedetti E, Viscido A, Castelli V, Maggiani C, d'Angelo M, Di Giacomo E, Antonosante A, Picarelli A, Frieri G.

J Cell Physiol. 2018 Jun;233(6):4383-4390. doi: 10.1002/jcp.26217. Epub 2018 Jan 4.

PMID:
29030981
11.

Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet.

Gabrieli D, Ciccone F, Capannolo A, Viscido A, Valerii G, Serva D, Necozione S, Coletti G, Calvisi G, Melideo D, Frieri G, Latella G.

United European Gastroenterol J. 2017 Oct;5(6):805-810. doi: 10.1177/2050640616684698. Epub 2017 Jan 18.

12.

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'IncĂ  R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis. 2017 Apr;49(4):338-358. doi: 10.1016/j.dld.2017.01.141. Epub 2017 Jan 17.

PMID:
28161290
13.

Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370].

Armuzzi A, Gionchetti P, Daperno M, Danese S, Orlando A, Scribano ML, Vecchi M, Rizzello F; GIVI (Gruppo Italiano su Vedolizumab nelle IBD) Group.

Dig Liver Dis. 2016 Sep;48(9):1103. doi: 10.1016/j.dld.2016.06.015. No abstract available.

PMID:
27555348
14.

The Role on Endoscopy in Alcohol-Related Diseases.

Frieri G, Galletti B, Serva D, Viscido A.

Rev Recent Clin Trials. 2016;11(3):196-200. Review.

PMID:
27515959
15.

Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea.

Capannolo A, Viscido A, Sollima L, Marinucci A, Coletti G, Pasetti A, Frieri G, Bassotti G, Villanacci V, Latella G.

Gastroenterol Hepatol. 2017 Aug - Sep;40(7):467-470. doi: 10.1016/j.gastrohep.2016.05.005. Epub 2016 Jul 18. English, Spanish. No abstract available.

PMID:
27436817
16.

Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease.

Armuzzi A, Gionchetti P, Daperno M, Danese S, Orlando A, Lia Scribano M, Vecchi M, Rizzello F; GIVI (Gruppo Italiano su Vedolizumab nelle IBD) Group.

Dig Liver Dis. 2016 Apr;48(4):360-70. doi: 10.1016/j.dld.2015.12.016. Epub 2016 Jan 7.

PMID:
26821929
17.

Association between vasomotor rhinitis and irritable bowel syndrome.

Lauriello M, Eibenstein A, Angelone AM, Pasqua M, Tucci C, Di Giacomo C, Salerno A, Frieri G, Fusetti M.

Allergy Rhinol (Providence). 2016 Jan 1;7(4):249-255. doi: 10.2500/ar.2016.7.0184.

18.

Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms.

Capannolo A, Viscido A, Barkad MA, Valerii G, Ciccone F, Melideo D, Frieri G, Latella G.

Digestion. 2015;92(1):8-13. doi: 10.1159/000430090. Epub 2015 May 30.

PMID:
26043918
19.

Nanotechnology in the treatment of inflammatory bowel diseases.

Viscido A, Capannolo A, Latella G, Caprilli R, Frieri G.

J Crohns Colitis. 2014 Sep;8(9):903-18. doi: 10.1016/j.crohns.2014.02.024. Epub 2014 Mar 28. Review.

20.

Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis.

Picarelli A, Di Tola M, Borghini R, Isonne C, Saponara A, Marino M, Casale R, Tiberti A, Pica R, Donato G, Frieri G, Corazziari E.

J Clin Immunol. 2013 Oct;33(7):1250-6. doi: 10.1007/s10875-013-9920-3. Epub 2013 Jul 6.

PMID:
23832583

Supplemental Content

Loading ...
Support Center